Investigation of Therapeutic Efficacy of Triazavirin Against Experimental Forest-Spring Encephalitis on Albino Mice
Abstract
The comparative study of the therapeutic efficacy of Triazavirin against experimental Forest-Spring encephalitis on albino mice vs. the active drug Ribavirin® showed that in high doses (200-400 mg/kg) Triazavirin moderately protected the infected animals. A significant increase of the animal lifespan in the test groups (from 4.1 to 4.8 days) and a statistically (p<0.05) valid decrease of the virus accumulation in the target organ (the brain) were observed.
Conflicts of Interest Disclosure:
The authors declares that there is no conflict of interest.
Article info:
Date submitted: 13.05.2020
All authors have read and approved the final manuscript.
Peer review info:
"Antibiot Khimioter = Antibiotics and Chemotherapy" thanks the anonymous reviewer(s) for their contribution to the peer review of this work.
Editorial comment:
In case of any discrepancies in a text or the differences in its layout between the pdf-version of an article and its html-version the priority is given to the pdf-version.
About the Authors
S. Ya. Loginova
Central Research Institute No. 48, Ministry of Defense of the Russian Federation
Россия
S. V. Borisevich
Central Research Institute No. 48, Ministry of Defense of the Russian Federation
Россия
V. L. Rusinov
Ural Federal University Named after the First President of Russia B. N. Yeltsin
Россия
E. N. Ulomsky
Ural Federal University Named after the First President of Russia B. N. Yeltsin
Россия
V. N. Charushin
Ural Federal University Named after the First President of Russia B. N. Yeltsin
Россия
O. N. Chupakhin
Ural Federal University Named after the First President of Russia B. N. Yeltsin
Россия
P. V. Sorokin
Ural Centre of Biopharmaceutical Technologies
Россия
References
1. Письмо Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека «О перечне эндемичных территорий по клещевому вирусному энцефалиту в 2014 году», № 01/126015-27 от 10.02.2015 г.
2. Письмо Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека «Об эпидемиологической ситуации по инфекциям, передающимся клещами, на территории Российской Федерации в 2014 году и прогнозе на 2015 год», № 01/2170-15-32 от 04.03.2015 г.
3. Логинова С.Я. Борисевич С.В., Русинов В.Л., Уломский У.Н., Чарушин В.Н, Чупахин О.Н. Изучение противовирусной активности триазавирина в отношении возбудителя клещевого энцефалита в культуре клеток. Антибиотики и химиотер 2014; 1-2: 3-5.
4. Руководство по экспериментальному (доклиническому) изучению новых фармакологических веществ. М.: Минздрав РФ, 2012.
For citations:
Loginova SY,
Borisevich SV,
Rusinov VL,
Ulomsky EN,
Charushin VN,
Chupakhin ON,
Sorokin PV.
Investigation of Therapeutic Efficacy of Triazavirin Against Experimental Forest-Spring Encephalitis on Albino Mice. Antibiotiki i Khimioterapiya = Antibiotics and Chemotherapy. 2015;60(7-8):11-13.
(In Russ.)
Views:
511
JATS XML